UNSPSC 51386611: Hydrocortisone/salicylic acid/sulfur

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE200. This VA Drug Class (DE200) classifies this compound as belonging to the group ANTI-INFLAMMATORY, TOPICAL.

UNSPSC 51386611 Hydrocortisone/salicylic acid/sulfur is a Commodity code that in practice covers pharmaceutical and medical supply procurement by state and local health agencies. The recent opportunity record shows a significant mismatch: Seminole County, Florida posted an IFB for naloxone and drug deactivation systems, neither of which are dermatological products aligned with the code's nominal scope of hydrocortisone-based skincare compounds. The code appears to show little relevant recent activity in state and local procurement, and the single available record suggests either misclassification at source or dormancy in the targeted commodity category itself.

Seminole County Community Health posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to 520 W. Lake Mary Blvd, Sanford, Florida. The response deadline was July 26, 2023, at 2:00 pm. Bidders were required to submit electronically, include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify requirements. The contract term was two years with an optional one-year renewal and included a three-month probationary termination clause. The procurement flagged potential FEMA funding and federal environmental compliance obligations. Given the code's narrow pharmaceutical focus and the absence of corroborating activity in recent opportunities, this category warrants monitoring for reclassification or renewed demand but does not present an active procurement opportunity under the stated commodity scope.